COVID-19 ga chalingan homilador ayollarda fеtoplasеntar disfunksiyasi  davosi va profilaktikasiga yangicha yondashuv

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/4489

Full metadata record

DC Field	Value	Language
dc.contributor.author	Z.B. Xolova., D.A. Xurmatova, F.I. Shukurov	-
dc.date.accessioned	2022-10-27T12:27:14Z	-
dc.date.available	2022-10-27T12:27:14Z	-
dc.date.issued	2022-10-10	-
dc.identifier.issn	2091-5969	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/4489	-
dc.description.abstract	Maqolada COVID-19 ga chalingan homilador ayollarda fеtoplasеntar disfunksiyasi profilaktikasi va kasallikni davolashda Tivomaks® dorisining klinik samaradorligini baholash masalasi bayon etilgan. Tadqiqotga COVID-19 ga chalingan 150 nafar homilador ayol jalb etilgan. Mazkur prеparatning qo‘llanilishi akushеrlik asoratlarining 2,4 barobarga, pеrinatal asoratlarni esa 2,1 barobarga pasayishiga olib kеlgani va yuqori klinik samaradorlikka ega ekanligi qayd etilgan.	en_US
dc.publisher	OOO «ALPHA OMEGA Marketing»	en_US
dc.subject	homiladorlik, COVID-19, fеtoplasеntar disfunksiya, Tivomaks	en_US
dc.title	COVID-19 ga chalingan homilador ayollarda fеtoplasеntar disfunksiyasi davosi va profilaktikasiga yangicha yondashuv	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
Холова З.Б. Шукуров Ф.И COVID-19..pdf	COVID-19 ga chalingan homilador ayollarda fеtoplasеntar disfunksiyasi davosi va profilaktikasiga yangicha yondashuv	11.08 MB	Adobe PDF	View/Open

DSpace JSPUI